P-321 Ophthalmic Solution

DRUG3 trials

Sponsors

Parion Sciences

Conditions

Dry Eye Disease

Phase 1

Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease

CompletedNCT02242032

Parion SciencesDry Eye Disease

Start: 2014-07-31End: 2015-03-31Updated: 2015-05-04

Phase 2

Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

TerminatedNCT02824913

Parion SciencesDry Eye Disease

Start: 2016-07-31End: 2017-03-31Updated: 2018-08-31

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

TerminatedNCT02831387

Parion SciencesDry Eye Disease

Start: 2016-07-31End: 2017-06-30Updated: 2018-10-11